# High-dose Chemotherapy+G-CSF in Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma

> **NCT05517213** · NA · COMPLETED · sponsor: **Affiliated Hospital to Academy of Military Medical Sciences** · enrollment: 62 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Etoposide
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT05517213
- **Lead sponsor:** Affiliated Hospital to Academy of Military Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05517213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05517213, "High-dose Chemotherapy+G-CSF in Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05517213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*